A TRPV2 Interactome-Based Signature for Prognosis in Glioblastoma Patients

Oncotarget - United States
doi 10.18632/oncotarget.24843
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

A 63 Signature Genes Prediction System Is Effective for Glioblastoma Prognosis

International Journal of Molecular Medicine
MedicineGenetics
2018English

A Network-Based Gene Expression Signature Informs Prognosis and Treatment for Colorectal Cancer Patients

PLoS ONE
Multidisciplinary
2012English

Isocitrate Dehydrogenase 1 (IDH1) Mutation-Specific microRNA Signature Predicts Favorable Prognosis in Glioblastoma Patients With IDH1 Wild Type

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2013English

A Multi-Parametric MRI-Based Radiomics Signature and a Practical ML Model for Stratifying Glioblastoma Patients Based on Survival Toward Precision Oncology

Frontiers in Computational Neuroscience
NeuroscienceCellularMolecular Neuroscience
2019English

Identification of a Multidimensional Transcriptome Signature for Survival Prediction of Postoperative Glioblastoma Multiforme Patients

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2018English

A Robust Signature Based on Autophagy-Associated LncRNAs for Predicting Prognosis in Lung Adenocarcinoma

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2020English

A MiRNA Signature for Defining Aggressive Phenotype and Prognosis in Gliomas

PLoS ONE
Multidisciplinary
2014English

Identification of a 13‑mRNA Signature for Predicting Disease Progression and Prognosis in Patients With Bladder Cancer

Oncology Reports
MedicineCancer ResearchOncology
2019English

Cellular-Based Immunotherapies for Patients With Glioblastoma Multiforme

Clinical and Developmental Immunology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy